Senior insider sale
Chief Strategy Officer at JANUX THERAPEUTICS, INC. — senior position signals high conviction
$1.86M
113.13K shares
What this filing means
ROBINSON BYRON plans to sell 113.13K shares of JANUX THERAPEUTICS, INC. valued at approximately $1.86M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/8/2025ACC: 0001950047-25-009961
Officer· Chief Strategy Officer
Since Mar 2022
113.13K
Shares to sell
$1.86M
Approx. market value
50K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
12/8/2025
50KTotal acquired50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/8/2025 | Stock Option Exercise Cash | 50K | — |
| Total | 50K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
63.13K
Market value
$1.03M
12/2/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
50K
Market value
$826.0K
12/8/2025
Total
Units
113.13K
Value
$1.86M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/2/2025 | 63.13K | $1.03M | — | Completed |
| Planned — Approximate Date | ||||
12/8/2025 | 50K | $826.0K | NASDAQ | Planned |
| Total | 113.13K | $1.86M | ||